New tests to quickly diagnose syphilis infections
Novel antigen tests for diagnosing active T. pallidum infection
This study is working on a quick and affordable test to check for active syphilis infections, so people can get accurate results in under 30 minutes and start treatment sooner.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-11098709 on NIH RePORTER |
What this research studies
This research aims to develop a rapid and cost-effective point-of-care diagnostic test for active syphilis infections caused by the bacterium Treponema pallidum. The current methods for diagnosing syphilis rely on older serum antibody tests that can be inaccurate and do not differentiate between current and past infections. By utilizing innovative Nano2RED technology, the study will create a test that can provide results in under 30 minutes with high sensitivity. This could significantly improve the accuracy of syphilis diagnoses and help in timely treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who may be at risk for syphilis or have symptoms of the infection.
Not a fit: Patients who are under 21 years old or those who have already been diagnosed and treated for syphilis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and faster diagnoses of syphilis, ultimately improving treatment outcomes and reducing the spread of the infection.
How similar studies have performed: Previous research has shown promise in developing rapid diagnostic tests for other infections, indicating potential success for this novel approach.
Where this research is happening
College Station, United States
- Texas A&m University Health Science Ctr — College Station, United States (Active)
Researchers
- Principal investigator: Chen, Zhilei — Texas A&m University Health Science Ctr
- Study coordinator: Chen, Zhilei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.